VERSONO Medical announces growth as it seeks to attract more talent

VERSONO Medical R&D engineers Dion Guilfoyle and Brian Tarpey.

VERSONO Medical R&D engineers Dion Guilfoyle and Brian Tarpey.

VERSONO Medical is an exciting early stage Irish MedTech company based in Galway, a global centre for excellence in medical technologies. The company collaborates with clinicians and research institutions across the world.

VERSONO’s mission is to transform the endovascular treatment of complex total occlusions and it is focused on commercialising its new technology platform for endovascular surgery that will focus initially on patients with Critical Limb Threatening Ischemia (CLTI ), the most severe and advanced clinical manifestation of Peripheral Arterial Disease PAD.

Versono’s mission is to enable endovascular treatment of Complex Total Occlusions, complete blockages of arteries, in order to alleviate pain, save limbs, and save lives. Addressing poor patient outcomes,high amputation and high mortality rates associated with CLTI is enormously challenging for patients, their families, physicians and healthcare systems globally.

VERSONO’s technology targets severe occlusions in CLTI patients, which presents one of the most challenging unmet needs in peripheral endovascular surgery. VERSONO’s Technology is designed to allow endovascular revascularisation by enabling therapeutic interventions to be used in severely diseased vessels.

VERSONO is growing as it continues to develop its pipeline of products. We are excited to announce openings in our team for talented individuals in the following areas : Senior Electronic Engineer, R&D Engineer , Associate Electronic Engineers and Quality/Documentation Specialist. If you are interested in an exciting career with Versono and have relevant experience, please submit your CV to [email protected]

 

Page generated in 0.3692 seconds.